The Cooper Companies Inc. (COO) - NYSE
  • Jul. 1, 2014, 6:56 AM
    • Cooper Companies (COO) will buy Sauflon Pharmaceuticals, a global supplier of contact lenses, for $1.2B. The deal is expected to add to EPS in fiscal 2015 on an adjusted basis.
    • COO -0.2% AH
    | Jul. 1, 2014, 6:56 AM
  • May 31, 2013, 5:27 PM
    Cooper Companies (COO) reaches an agreement to sell Aime, its rigid gas permeable contact lens and solutions business in Japan, to Nippon Contact Lens. Financial terms of the transaction were not disclosed. The business was obtained in 2010 as part of an acquisition which included obtaining the rights to sell Biofinity in Japan, but the company has continually suffered declining revenue and lower than average company margins.
    | May 31, 2013, 5:27 PM
  • May 24, 2013, 2:34 PM
    Cooper Companies (COO +2.1%) moves up in the slipstream created from reports that its rival Bausch & Lomb is near a deal to be acquired by Valeant (VRX) for $9 billion.
    | May 24, 2013, 2:34 PM
  • Jun. 4, 2012, 3:55 PM

    Cooper Cos. (COO -4.3%) makes a move to expand into the women's health-care market by announcing plans to acquire Danish medical-device company Origio A/S through a roughly $151M tender offer.

    | Jun. 4, 2012, 3:55 PM
Company Description
The Cooper Cos, Inc. is a medical device company. It operates through two business units: Cooper Vision and Cooper Surgical. The Cooper Vision business unit brings a refreshing perspective on vision care with a commitment to crafting quality lenses for contact lens wearers. The Cooper Surgical... More
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: United States